FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:849-850 September 9, 1999 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

To the Editor: In a recent letter, Capuron and Ravaud described their use of a depression rating scale as a method of predicting depressive symptoms associated with high doses of interferon alfa (April 29 issue).¹ We strongly endorse the authors' recommendation of a routine psychiatric assessment before treatment with interferon alfa. However, we consider their conclusions — that "the effects of interferon alfa on mood depend on the initial affective state of the patients" and that a base-line measurement of mood symptoms constitutes "an easy way to identify patients who are at risk for mood disorders" — to be both . . . [Full Text of this Article]

References

Related Letters:

Prediction of the Depressive Effects of Interferon Alfa Therapy by the Patient's Initial Affective State
Capuron L., Ravaud A.
Extract | Full Text  
N Engl J Med 1999; 340:1370, Apr 29, 1999. Correspondence

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.